Switch Bolsters Leadership and R&D Footprint as Biofertilizer Platform Enters Scale-Up Phase

Switch, also referred to as Switch Bioworks, is a biotechnology company focused on biologically powered, sustainable fertilizer solutions, and this weekly recap highlights a pivotal period of organizational and operational scale-up. Over the past week, the company announced a substantial expansion of its leadership team, operational footprint, and advisory network, underscoring a transition from early-stage research toward scaled development and commercialization readiness.

The company strengthened its executive bench with three key C-suite appointments: Steve del Cardayre as Chief Technology Officer, Brett Boghigian as Chief Business Officer, and climate-tech veteran Kaitlyn Qin as Chief Financial Officer. Collectively, these leaders bring deep experience in industrial and agricultural biotechnology, commercialization strategy, finance, and capital planning, positioning Switch to better manage product development, regulatory planning, and go-to-market execution for its biofertilizer platform.

Operationally, Switch relocated to a new headquarters in San Carlos, California, tripling its R&D footprint and consolidating fermentation, plant growth rooms, laboratories, and offices into a single facility. This move is designed to increase experimental throughput, support larger-scale trials, and enhance coordination across research, development, and business operations. The company also continued to build its technical team with the hiring of Senior Research Associate Jose Zaragoza, whose prior experience at Ginkgo Bioworks and Bayer Cropscience bolsters Switch’s capabilities in microbiology and agricultural R&D.

The company reinforced its legal and strategic foundations by appointing Liz Freeman Rosenzweig as Senior Counsel to oversee intellectual property, regulatory, legal, and government affairs. This role is expected to support the development of a defensible IP portfolio and smoother regulatory engagement for genetically engineered fertilizer products. Advisory strength increased as agrifood industry veteran Eric Bartels joined as an advisor, while board member Doug Cameron and founding advisor Jennifer Cochran were elected to the National Academy of Engineering, enhancing Switch’s external credibility.

On the scientific and industry engagement front, Switch’s leadership presented at major events including the Microbiome AgBio Tech Summit and the European Nitrogen Fixation Conference, showcasing work on microbial consortia and engineered genetic circuits for climate-focused, cost-effective biofertilizers. Internally, the company held an annual off-site focused on communication, strategic alignment, and team building, alongside ongoing hiring efforts.

Taken together, these developments indicate that Switch is investing heavily in leadership, infrastructure, and organizational capacity to support the scale-up of its sustainable nitrogen solutions. While specific financial metrics and commercialization timelines were not disclosed, the company’s strengthened operational and scientific foundations appear to improve its positioning for future field validation, partnerships, and eventual market entry. Overall, the week marked a notable step forward in Switch’s evolution from a research-centric startup toward a more commercialization-ready ag-biologicals player.